Growing Little PEAPODS Preterm Baby Study
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study follows the growth and body composition of very premature babies (born between 22 and 32 weeks) to learn how they develop. It uses a special device called the PEAPOD to measure body fat, which may help improve care for preemies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born between 22 weeks and 32 weeks 6 days of pregnancy.
- Your baby cannot have a known genetic condition that affects brain development or major birth defects.
- You must speak English or Spanish and be at least 15 years old.
- You plan to keep custody of your baby after birth.
- You are willing to follow all study steps and be available for the whole study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at premature babies to find out which ones are likely to have trouble growing while in the hospital. The goal is to help doctors identify and support babies who may need extra nutrition or care.
This study collects health information and biological samples from very premature babies to understand what affects their development. It may help researchers find ways to improve care and outcomes for infants like yours.
This study looks at how very small premature babies (born early and weighing less than 4.4 pounds at discharge) do after they go home. It helps doctors understand what support families need.
This study looks at blood markers to find women at risk for placental problems during pregnancy. It involves blood tests in early and late pregnancy, and at birth, to see how iron levels and other factors affect the placenta and baby's health.
This study tests whether a gentle mouth care routine combined with a special feeding schedule helps preterm babies start eating by mouth more quickly and gain weight. It is designed for stable preterm infants born at 29-33 weeks.
This study tests a decision-support tool (a structured way to guide conversations) for parents facing a high risk of delivering very early (about 22–26 weeks). It may help you and your baby’s care team make clearer, more aligned choices about neonatal (newborn) treatment.
Hear when a new Premature Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.